A comparative study of an estradiol-releasing vaginal ring versus tibolone in postmenopausal women: A transvaginal color Doppler study

Maturitas

Volumn 27, Issue 1, 1997, Pages 77-83

  Botsis, D ^a   Kassanos, D ^a   Kalogirou, D ^a   Antoniou, G ^a,c   Karakitsos, P ^b   Zourlas, P A ^a  

^a UNIVERSITY OF ATHENS   (Greece)

^b LAIKO GENERAL HOSPITAL   (Greece)

^c NONE   (Greece)

Author keywords

endometrial blood flow; estrogen replacement therapy; tibolone; transvaginal Doppler; vaginal ring

Indexed keywords

ESTRADIOL; TIBOLONE;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; ENDOMETRIUM; FEMALE; HORMONE SUBSTITUTION; HUMAN; MAJOR CLINICAL STUDY; POSTMENOPAUSE; TRANSVAGINAL ECHOGRAPHY; VASCULAR RESISTANCE; VASODILATATION;

ANABOLIC AGENTS; ENDOMETRIUM; ESTRADIOL; ESTROGENS; FEMALE; HUMANS; MIDDLE AGED; NORPREGNENES; OSTEOPOROSIS, POSTMENOPAUSAL; POSTMENOPAUSE; ULTRASONOGRAPHY, DOPPLER, COLOR;

EID: 0030919335     PISSN: 03785122     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-5122(97)01105-5     Document Type: Article

References (33)

1. Josif CS, Benassy Z. Prevalence of genitourinary symptoms in the late menopause. Acta Obstet Gynecol Scand 1984; 63: 257-260.
2. Mettler L, Olsen PG. Vaginal administration of low dose estradiol. Safety and efficiency in long-term treatment of atrophic vaginitis. Maturitas 1991; 14: 23-31.
3. Maudel FP, Geola FL, Meldnum DR, Lu JHK, Eggns P, Sambin M der P, Hershman JM, Judd HL. Biological effects of various doses of vaginally administered conjugated estrogens in postmenopausal women. J Clin Endocrinol Metabol 1983; 57: 133.
4. Genazzani AR et al. Org OD 14 and the endometrium. Maturitas 1991; 13: 243-251.
5. Trevoux R, Dieulangard P, Blum A. Efficacy and safety of ORG OD 14 in the treatment of climacteric complaints. Maturitas 1983; 89-96.
6. Bourne TH, Campbell S. Whitehead MI, Royston P, Steer CV, Collins WP. Detection of endometrial cancer in postmenopausal women by transvaginal ultrasonography and color flow imaging. Br Med J 1990; 299: 369-373.
7. Kurjak A, Shalan H, Sosic A, Benic S, Zudenigo D, Kupesic S, Predanic M. Endometrial carcinoma in postmenopausal women: evaluation by transvaginal color Doppler ultrasonography. Am J Obstet Gynecol 1993; 169: 1597-1603.
8. Schmidt G, Andersson S-B, Nordle O, Johansson C-J, Gunnarsson PO. Release of 17-beta-Oestradiol from a vaginal ring in postmenopausal women: pharmacokinetic evaluation. Gynecol Obstet Invest 1994; 38: 253-260.
9. Stumpf PG, Maruca J, Sauten RJ, Demers L. Development of a vaginal ring for achieving physiologic levels of 17β-estradiol in hypoestrogenic women. J Clin Endocrinol Metab 1982; 54: 208-210.
10. Holmgren PA, Lindskog M, von Schoultz B. Vaginal rings for continuous low-dose release of oestradiol in treatment of urogenital atrophy. Maturitas 1989; 11: 55-63.
11. Smith P, Heimer G, Lindskog M, Ulmsten U. Estradiol-releasing vaginal ring for treatment of postmenopausal urogenital atrophy. Maturitas 1993; 16: 145-154.
12. Narsi MN, Shepherd JH, Setchell ME, et al. The role of vaginal scan in measurement of endometrial thickness in postmenopausal women. Br J Obstet Gynaecol 1991; 98: 470-475.
13. Varner RE, Sparks JM, Cameron CD, Roberts LL, Soong S-J. Transvaginal sonography of the endometrium in postmenopausal women. Obstet Gynecol 1991; 78: 195.
14. Holbert TR. Screening transvaginal ultrasonography of postmenopausal women in a private office setting. Am J Obstet Gynecology 1994; 170: 1699-1704.
15. Andersson SB. Development pharmaceutics of an estradiol-releasing vaginal silicone ring. Uppsala, Sweden: Kabi Pharmacia AB 1992; research report no 20230 F.
16. Martin PL, Yen SSC, Burnier AAM, Hermann H. Systemic absorption and sustained effects on vaginal estrogen creams. J Am Med Assoc 1979; 242: 2699-2700.
17. Hargrove JT, Maxson WS, Colston WA, Burnett LS. Menopausal hormone replacement therapy with continuous daily oral micronized estradiol and progesterone. Obstet Gynecol 1989; 73: 606-612.
18. Gerbaldo D, Ferraiolo A, Crose S, Trinini M, Capitano GL. Endometrial morphology after 12 months of vaginal oestriol therapy in postmenopausal women. Maturitas 1991; 13: 269-274.
19. Wildholm O, Vartiainen E. The absorption of conjugated oestrogen and sodium oestrone sulfate from the vagina. Ann Chir Gynaecol Fenn 1974; 63: 186-190.
20. Luisi M, Franchi F, Kicovic PM. A group-comparative study of effects of Ovestin cream versus Premarin cream in postmenopausal women with vaginal atrophy. Maturitas 1980; 2: 309-311.
21. Van der Vies J. Pharmacological studies with ORG OD 14. Maturitas 1987; Suppl. 1: 25-24.
22. Benedek-Jaszman LJ. Long-term placebo-controlled efficacy and safety study of ORG OD 14 in climacteric women. Maturitas 1987; Suppl: 1: 25-33.
23. Tax L, Goorissen EM, Kieovic PM. Clinical profile of Org OD 14. Maturitas 1987; Suppl. 1: 3-13.
24. Rosenfeld CR, Jackson GM. Induction and inhibition of uterine vasodilatation by catechol estrogen in oophorectomized non pregnant ewes. Endocrinology 1982; 110: 1333-1339.
25. Rosenfeld CR, Morris FJ, Battaglia FC, Makowski EL, Meschia G. Effect of estradiol on blood flow to reproductive and non reproductive tissues in pregnant ewes. Am J Obstet Gynecol 1976; 124: 618-629.
26. Mangness RR, Rosenfeld CR. The role of steroid hormones in the control futerine blood flow. In: Rosenfeld CR, editor. The Uterine blood flow. New York: Perinatology Press, 1989; 239-271.
27. Hafez ESE. The vagina and human reproduction. Am J Obstet Gynecol 1977; 129: 573-584.
28. Trevoux R, van der Weiden WH, Popovic D. Ovestin vaginal cream and suppositories for the treatment of menopausal vaginal atrophy. Reproduction 1982; 6: 101-106.
29. Raz R, Stamm WE. A controlled trial of intra-vaginal estriol in postmenopausal women with recurrent urinary tract infections. New Engl J Med 1993; 329: 753-756.
30. Carlstrom K, Karlgren E, Furuhjelm M. Effects of intravaginal oestrogen treatment upon the vaginal absorption of conjugated equine oestrogens. Maturitas 1982; 4: 277-283.
31. Kurjak A, Shalan H, Kupesic S, Predanic M, Zalud I, Breyer B, Jukics S. Transvaginal color Doppler sonography in the assessment of pelvic tumor vascularity. Ultrasound Obstet Gynecol 1993; 3: 137-154.
32. Merce LT, Lopez-Garcia G, De la Feunte F. Doppler ultrasound assessment of the endometrial pathology. Acta Obstet Gynecol Scand 1991; 70: 525-530.
33. Achiron R, Lipitz S, Frenuel Y, Mashiach S. Endometrial blood flow response to estrogen replacement therapy and tamoxifen in asymptomatic, postmenopausal women: a transvaginal Doppler study. Ultrasound Obstet Gynecol 1995; 5: 411-414.